中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2008年
5期
306-309
,共4页
李恩山%马幼平%刘学键%张春清
李恩山%馬幼平%劉學鍵%張春清
리은산%마유평%류학건%장춘청
高血压%门静脉%胃肠出血/病因学%栓塞
高血壓%門靜脈%胃腸齣血/病因學%栓塞
고혈압%문정맥%위장출혈/병인학%전새
Hypertension,portal%Gastrointestinal hemorrhage/etiology%Embolization
目的 探讨经皮经肝食管胃底静脉栓塞术联合部分脾脏栓塞术对门脉高压性胃病(PHG)的影响.方法 采用经皮经肝TH胶定位栓塞胃冠状静脉(必要时联合栓塞胃短和胃后静脉)联合脾部分栓塞术(PTVE+PSE),治疗肝硬化门脉高压症并上消化道出血病人53例.以48例行脾次全切除腹膜后移位加断流术的病人为对照,进行对比研究.随访2~48个月,平均16个月.结果 (1)成功率:PTVE为92.3%,PSE达100%,PTVE死亡率1.9%,急症止血率100%,再出血率4.2%(对照组5.5%).(2)研究组栓塞2个月、1年与栓塞前相比,PHG无明显变化(P>0.05);对照组术后2个月PHG程度比术前加重(P<0.05),术后1年比术前减轻(P<0.05);研究组与对照组相比,PHG的变化无显著性差异(P>0.05).(3)研究组术后满1年的43例食管胃底静脉曲张者中,好转27例,消失7例,无变化8例,加重1例,而对照组47例中,好转25例,消失9例,无变化13例,两组疗效相似(P>0.05).(4)两组治疗结束时自由门静脉压力(FPP)均明显下降,研究组FPP平均减少(0.23±0.72)kPa,对照组平均减少(0.24±0.57)kPa.(5)研究组脾亢44例治愈,4例复发,复发者再次行PSE,脾亢消失.结论 联合介入栓塞术疗效明显,止血确切,降低门脉压力显著,没有加重PHG,达到与脾次全切除腹膜后移位加断流术相似疗效.
目的 探討經皮經肝食管胃底靜脈栓塞術聯閤部分脾髒栓塞術對門脈高壓性胃病(PHG)的影響.方法 採用經皮經肝TH膠定位栓塞胃冠狀靜脈(必要時聯閤栓塞胃短和胃後靜脈)聯閤脾部分栓塞術(PTVE+PSE),治療肝硬化門脈高壓癥併上消化道齣血病人53例.以48例行脾次全切除腹膜後移位加斷流術的病人為對照,進行對比研究.隨訪2~48箇月,平均16箇月.結果 (1)成功率:PTVE為92.3%,PSE達100%,PTVE死亡率1.9%,急癥止血率100%,再齣血率4.2%(對照組5.5%).(2)研究組栓塞2箇月、1年與栓塞前相比,PHG無明顯變化(P>0.05);對照組術後2箇月PHG程度比術前加重(P<0.05),術後1年比術前減輕(P<0.05);研究組與對照組相比,PHG的變化無顯著性差異(P>0.05).(3)研究組術後滿1年的43例食管胃底靜脈麯張者中,好轉27例,消失7例,無變化8例,加重1例,而對照組47例中,好轉25例,消失9例,無變化13例,兩組療效相似(P>0.05).(4)兩組治療結束時自由門靜脈壓力(FPP)均明顯下降,研究組FPP平均減少(0.23±0.72)kPa,對照組平均減少(0.24±0.57)kPa.(5)研究組脾亢44例治愈,4例複髮,複髮者再次行PSE,脾亢消失.結論 聯閤介入栓塞術療效明顯,止血確切,降低門脈壓力顯著,沒有加重PHG,達到與脾次全切除腹膜後移位加斷流術相似療效.
목적 탐토경피경간식관위저정맥전새술연합부분비장전새술대문맥고압성위병(PHG)적영향.방법 채용경피경간TH효정위전새위관상정맥(필요시연합전새위단화위후정맥)연합비부분전새술(PTVE+PSE),치료간경화문맥고압증병상소화도출혈병인53례.이48례행비차전절제복막후이위가단류술적병인위대조,진행대비연구.수방2~48개월,평균16개월.결과 (1)성공솔:PTVE위92.3%,PSE체100%,PTVE사망솔1.9%,급증지혈솔100%,재출혈솔4.2%(대조조5.5%).(2)연구조전새2개월、1년여전새전상비,PHG무명현변화(P>0.05);대조조술후2개월PHG정도비술전가중(P<0.05),술후1년비술전감경(P<0.05);연구조여대조조상비,PHG적변화무현저성차이(P>0.05).(3)연구조술후만1년적43례식관위저정맥곡장자중,호전27례,소실7례,무변화8례,가중1례,이대조조47례중,호전25례,소실9례,무변화13례,량조료효상사(P>0.05).(4)량조치료결속시자유문정맥압력(FPP)균명현하강,연구조FPP평균감소(0.23±0.72)kPa,대조조평균감소(0.24±0.57)kPa.(5)연구조비항44례치유,4례복발,복발자재차행PSE,비항소실.결론 연합개입전새술료효명현,지혈학절,강저문맥압력현저,몰유가중PHG,체도여비차전절제복막후이위가단류술상사료효.
Objective To study the effect of dual interventional embolization on portal hypertensive gastropathy. Methods In the treated group, percutaneous transhepatic varicieal embolization with TH glue combining with partial splenic embolization was performed in 53 patients of cirrhosis due to portal hypertension. In control group, 48 patients were treated by subtotal splenectomy with retroperitoneal splenic transposition and devascularization. The follow-up period ranged from 2 to 48 months (mean=16 months ). Results 1) In the treated group, the successful rates of PTVE and PSE were 92.3% and 100%, respectively. The rates of emergency controlling, hemorrhage, rebleeding and death were 100%, 4.2% and 1.9%, respectively. In the control group, the rate of rebleeding was 5.5%. 2) In 2 months and 1 year after operation, PHG remained unchanged compared with that before operation in the treated group. In the control group, PHG in 2 months after operation was significantly aggravated compared with that before(P<0.05). In 1 year after operation, PHG was significantly improved (P<0.05). There was no significant difference between the two groups in change of PHG (P>0.05). 3) In the treated group, the rates of disappearance, improvement, absence of change and aggravation were 62.7%, 16.3%, 18.6%, 2.3%, respectively. In the control group, the rate of disappearance was 53.1%, that of improvement 19.1% and that of absence of change 27.7%.There was no significant difference between the two groups (P>0.05). 4) Free pressure of portal vein (FPP) was significantly declined after operation in both groups. The average decline of FPP was (0.23±0.72)kPa and (0.24±0.57) kPa in the treated group and control group, respectively. 5) The rate of disappearance of hypersplenism was 91.7% (44/48). Conclusion Dual interventional embolization has the advantage of controlling varieeal hemorrhage and declining portal vein pressure but not aggravating PHG. This method has a similar effect of subtotal spleneetomy with retroperitoneal splenic transposition and devascularization.